GE Healthcare tested a radioactive contrasting agent that can track the growth pattern of new blood vessels that feed tumors. This can help doctors scan and treat cancer patients. This experimental agent binds to the blood vessels, helping doctors not only monitor new vessel production and growth, but also identify the exact dimension of a tumor. To help determine the effectiveness of the treatment and the proper dosage of a drug, the tumor then can be monitored during chemotherapy.
The company, a unit of General Electric Co. and the world’s largest manufacturer of imaging equipment plan to start trialing the agent on human within months. The Company uses the agent with positron emission tomography, or PET. This creates body images from positrons — tiny radioactive particles. The PET scans were performed mostly on cancer patients.
Via: Reuters
GE tests 'New radioactive agent' to detect cancer
Add Your Comment
Fresh Comments
on New technology uses LCD... Light bending techniques are very innovative. This technology should be optimally...
on GM 'fearless' mice may never... I really can’t imagine what is going to happen to the cats... Where are Tom and...
on Scientists become Gods,... To genetic have been become a prominant baranch of medical science due to its...
on New technology uses LCD... This process usually takes place due to powerful gravitational fields produced by massive...
on New technology uses LCD... We’ve always believed that light travels in the universe in a straight trajectory....